Tuberous Sclerosis 1; Tsc1
Description
Tuberous sclerosis complex (TSC) is an autosomal dominant multisystem disorder characterized by hamartomas in multiple organ systems, including the brain, skin, heart, kidneys, and lung. Central nervous system manifestations include epilepsy, learning difficulties, behavioral problems, and autism. Renal lesions, usually angiomyolipomas, can cause clinical problems secondary to hemorrhage or by compression and replacement of healthy renal tissue, which can cause renal failure. Patients can also develop renal cysts and renal-cell carcinomas. Pulmonary lymphangioleiomyomatosis can develop in the lungs. Skin lesions include melanotic macules, facial angiofibromas, and patches of connective tissue nevi. There is a wide clinical spectrum, and some patients may have minimal symptoms with no neurologic disability (reviews by Crino et al., 2006 and Curatolo et al., 2008).
Clinical Features
Top most frequent phenotypes and symptoms related to Tuberous Sclerosis 1; Tsc1
- Intellectual disability
- Seizures
- Neoplasm
- Pain
- Hypertension
- Respiratory distress
- Hydrocephalus
- Vomiting
- Congestive heart failure
- Behavioral abnormality
And another 82 symptoms. If you need more information about this disease we can help you.
Incidence and onset information
— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)— No data available about the known clinical features onset.
Alternative names
Tuberous Sclerosis 1; Tsc1 Is also known as tuberous sclerosis complex, ts, tuberose sclerosis, tsc.
Researches and researchers
Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.Tuberous Sclerosis 1; Tsc1 Recommended genes panels
Panel Name, Specifity and genes Tested/covered |
---|
PreSeek Non-invasive Prenatal Gene Sequencing Screen.
By Baylor Miraca Genetics Laboratories (United States).
RIT1, BRAF, SMC1A, SOS1, SOS2, CDKL5, SYNGAP1, TSC1, TSC2, HDAC8, NSD1, CBL, SHOC2, CHD7, COL1A2, SMC3, NIPBL, FGFR2, FGFR3, HRAS , (...)
View the complete list with 9 more genes
Specificity
4 %
Genes
100 % |
TSC1 Deletion Analysis.
By Athena Diagnostics Inc (United States).
TSC1
Specificity
100 %
Genes
100 % |
TSC Familial Mutation Evaluation.
By Athena Diagnostics Inc (United States).
TSC1, TSC2
Specificity
50 %
Genes
100 % |
TSC1 Sequencing Test.
By Athena Diagnostics Inc (United States).
TSC1
Specificity
100 %
Genes
100 % |
Epilepsy Advanced Sequencing and CNV Evaluation.
By Athena Diagnostics Inc (United States).
SCN1A, SCN1B, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A, SHH, ST3GAL3, ST3GAL5, STIL, SIX3, SLC2A1, SLC35A2, SLC6A1, SLC6A8, SLC9A6, SMC1A, KDM5C, SMS , (...)
View the complete list with 214 more genes
Specificity
1 %
Genes
100 % |
Epilepsy Advanced Sequencing and CNV Evaluation - Syndromic Disorders.
By Athena Diagnostics Inc (United States).
SYNGAP1, TBX1, TSC1, TSC2, SETBP1, PANK2, ADGRV1, ATP6V0A2, MAGI2, VPS13A, ANKRD11, VPS13B, KIF1BP, KANSL1, SMC3, PIGV, NIPBL, ROGDI, GFAP, HPRT1 , (...)
View the complete list with 11 more genes
Specificity
4 %
Genes
100 % |
Complete Tuberous Sclerosis Sequencing and CNV Evaluation.
By Athena Diagnostics Inc (United States).
TSC1, TSC2
Specificity
50 %
Genes
100 % |
TSC1 CNV Test.
By Athena Diagnostics Inc (United States).
TSC1
Specificity
100 %
Genes
100 % |
You can get up to 227 more panels with our dedicated tool
Learn moreSources and references
You can check the following sources for additional information.
OMIM Rare Disease Symptoms CheckerIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 5; SMDP5